Stay updated on Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Recruitment has been marked as closed ('No longer looking for participants'), indicating no current enrollment. The page also adds several help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label to v3.6.0, reflecting UI and metadata changes.
    Difference
    0.4%
    Check dated 2026-06-16T05:46:35.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5. This signals a small update to the page's documentation framework or platform version.
    Difference
    0.0%
    Check dated 2026-06-09T02:41:08.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a topical tag 'Lung cancer' and a 'related topics' section with a link to MedlinePlus Genetics. These changes enhance navigation and provide quick context related to the study's medical domain.
    Difference
    0.1%
    Check dated 2026-06-02T01:08:38.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now shown, and older items such as Revision: v3.5.3 and some related topic labels (Lung cancer, MedlinePlus Genetics) were removed, reflecting a metadata/navigation cleanup on the page.
    Difference
    0.2%
    Check dated 2026-05-18T13:58:11.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from v3.5.0 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-27T08:13:53.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added related topics: Lung cancer and MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-04-13T01:46:31.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.